Skip to main content
. Author manuscript; available in PMC: 2014 Oct 20.
Published in final edited form as: J Immunol. 2014 Sep 19;193(9):4663–4674. doi: 10.4049/jimmunol.1401608

Figure 2.

Figure 2

Serum levels in naïve ELL2loxp/loxp CD19cre/+ mice are reduced with both exon 1 and exon 3 deletions. Control mice with either ELL2loxp/loxp CD19+/+ or ELL2+/+ CD19cre/+ (filled symbols, designated wt) and the ELL2 loxp/loxp CD19 cre/+ mice (open symbols, designated cKO) were bled at 7, 12 and 17 weeks. Serum was analyzed by ELISA for the indicated isotypes. P= 0.05 (*), 0.01 (**), or 0.001 (***) as indicated on graphs.